GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Map2 | decreases expression | EXP | | 6480464 | CTD | Rotenone results in decreased expression of MAP2 mRNA | PMID:32481507 | Map2 | decreases expression | ISO | MAP2 (Homo sapiens) | 6480464 | CTD | Rotenone results in decreased expression of MAP2 mRNA | PMID:33512557 | Map2 | decreases expression | ISO | Map2 (Mus musculus) | 6480464 | CTD | Rotenone results in decreased expression of MAP2 protein | PMID:35919817 | Map2 | multiple interactions | ISO | MAP2 (Homo sapiens) | 6480464 | CTD | Rotenone inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA] | PMID:32949729 | |
Go Back to source page | Continue to Ontology report |